| Updated risk models demonstrate low risk of symptomatic radionecrosis following stereotactic radiosurgery for brain metastases L Peng, J Grimm, C Gui, CJ Shen, KJ Redmond, L Sloan, S Hazell, ... Surgical Neurology International 10, 2019 | 19 | 2019 |
| Tumor-treating field arrays do not reduce target volume coverage for glioblastoma radiation therapy GC Stachelek, J Grimm, J Moore, E Huang, N Spoleti, KJ Redmond, ... Advances in Radiation Oncology 5 (1), 62-69, 2020 | 15 | 2020 |
| A dose-response model of local tumor control probability after stereotactic radiosurgery for brain metastases resection cavities C Gui, J Grimm, LR Kleinberg, P Zaki, N Spoleti, D Mukherjee, ... Advances in Radiation Oncology 5 (5), 840-849, 2020 | 7 | 2020 |
| Clinical evidence for dose tolerance of the central nervous system in hypofractionated radiotherapy J Xue, B Emami, J Grimm, GJ Kubicek, SO Asbell, R Lanciano, JS Welsh, ... Journal of Radiation Oncology 7, 293-305, 2018 | 2 | 2018 |
| A Dose-Response Model of Local Tumor Control Probability after Stereotactic Radiosurgery for Brain Metastases Resection Cavities C Gui, LR Kleinberg, M Lim, J Grimm, P Zaki, N Spoleti, C Bettegowda, ... International Journal of Radiation Oncology, Biology, Physics 105 (1), E76, 2019 | | 2019 |
| The Lessons of QUANTEC Reproduced in HyTEC J Grimm, C Gui, M Deek, KB Kim, N Spoleti Cureus Journal of Medical Science 11 (3), 2019 | | 2019 |
